Cargando…
Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma
The three oncogenes, ErbB receptors, Ras proteins and nucleolin may contribute to malignant transformation. Previously, we demonstrated that nucleolin could bind both Ras protein and ErbB receptors. We also showed that the crosstalk between the three proteins facilitates anchorage independent growth...
Autores principales: | Goldshmit, Yona, Trangle, Sari Schokoroy, Kloog, Yoel, Pinkas-Kramarski, Ronit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226707/ https://www.ncbi.nlm.nih.gov/pubmed/25261371 |
Ejemplares similares
-
Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
por: Wolfson, Eya, et al.
Publicado: (2018) -
Disrupting the Oncogenic Synergism between Nucleolin and Ras Results in Cell Growth Inhibition and Cell Death
por: Schokoroy, Sari, et al.
Publicado: (2013) -
Identification of Nucleolin as New ErbB Receptors- Interacting Protein
por: Di Segni, Ayelet, et al.
Publicado: (2008) -
Structure-Function Analysis of Nucleolin and ErbB Receptors Interactions
por: Farin, Keren, et al.
Publicado: (2009) -
Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer
por: Wolfson, Eya, et al.
Publicado: (2016)